Attention deficit hyperactivity disorder and substance use disorders.

Attention deficit hperactivity disorder (ADHD) is highly prevalent among adolescents who have substance use disorder (SUD). Several lines of evidence, although not conclusive, suggest that ADHD might have an independent effect on SUD liability. It is still to be determined, however, whether this association is mediated by conduct disorder. This article reviews ADHD and SUD.

[1]  R. Wise,et al.  A psychomotor stimulant theory of addiction. , 1987, Psychological review.

[2]  T. Rugino,et al.  Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  Edythe D London,et al.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. , 2006, Archives of general psychiatry.

[4]  The Neurobiology of Drug Addiction , 1997 .

[5]  W. Pelham,et al.  Coping skills and parent support mediate the association between childhood attention-deficit/hyperactivity disorder and adolescent cigarette use. , 2005, Journal of pediatric psychology.

[6]  F. Castellanos,et al.  Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. , 2008, The American journal of psychiatry.

[7]  E. Nestler,et al.  Epigenetic mechanisms in drug addiction. , 2008, Trends in molecular medicine.

[8]  S. Kollins,et al.  Assessing methylphenidate preference in ADHD patients using a choice procedure , 2004, Psychopharmacology.

[9]  K. Scheibe,et al.  Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  D. Lynam,et al.  Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit/hyperactivity disorder and conduct disorder are uniquely at risk. , 2003, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[11]  R. Williams,et al.  Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. , 2004, The American journal on addictions.

[12]  R. Todd,et al.  Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: evidence for association of an intronic polymorphism with attention problems , 2003, Molecular Psychiatry.

[13]  C. Yen,et al.  Psychiatric and psychosocial predictors of substance use disorders among adolescents , 2007, British Journal of Psychiatry.

[14]  Nora D Volkow,et al.  Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. , 2003, The American journal of psychiatry.

[15]  L. Demilio,et al.  Psychiatric syndromes in adolescent substance abusers. , 1989, The American journal of psychiatry.

[16]  R. Murray,et al.  A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Svensson,et al.  Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome , 1998, Brain Research.

[18]  J. Swanson,et al.  Evaluating dopamine reward pathway in ADHD: clinical implications. , 2009, JAMA.

[19]  J. Swanson,et al.  Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[20]  Joseph Biederman,et al.  Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. , 2007, Journal of pediatric psychology.

[21]  N. Lambert,et al.  Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants , 1998, Journal of learning disabilities.

[22]  J. L. Kenemans,et al.  Acute effects of nicotine on attention and response inhibition , 2005, Pharmacology Biochemistry and Behavior.

[23]  R. Kessler,et al.  Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. , 2007, The British journal of psychiatry : the journal of mental science.

[24]  R. Tarter.  Etiology of adolescent substance abuse: a developmental perspective. , 2002, The American journal on addictions.

[25]  H. Flor,et al.  Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics , 2004, Psychopharmacology.

[26]  Nora D Volkow,et al.  Psychopharmacology: concepts and opinions about the use of stimulant medications. , 2009, Journal of child psychology and psychiatry, and allied disciplines.

[27]  M. Solanto.  Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration , 1998, Behavioural Brain Research.

[28]  B. Leventhal,et al.  Attention deficit hyperactivity disorder and whole-blood serotonin levels: effects of comorbidity , 1995, Psychiatry Research.

[29]  W. Pelham,et al.  Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. , 2003, Journal of abnormal psychology.

[30]  K. Berridge,et al.  The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.

[31]  H. Wechsler,et al.  Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. , 2005, Addiction.

[32]  S. Gordon,et al.  Prevalence and Characteristics of Adolescent Patients with Co-Occurring ADHD and Substance Dependence , 2004, Journal of addictive diseases.

[33]  H. Coşkunol,et al.  Childhood attention deficit/hyperactivity disorder and alcohol dependence: a 1-year follow-up. , 2003, Alcohol and alcoholism.

[34]  Jill U. Adams,et al.  Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  J. English,et al.  Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD) , 2009, Psychopharmacology.

[36]  S. McCabe,et al.  Medical Use, Illicit Use and Diversion of Prescription Stimulant Medication , 2006, Journal of psychoactive drugs.

[37]  G. Badger,et al.  Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. , 2002, Drug and alcohol dependence.

[38]  S. Faraone,et al.  Is ADHD a risk factor for psychoactive substance use disorders : Findings from a four-year prospective follow-up study , 1997 .

[39]  F. J. McClernon,et al.  Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. , 2005, Archives of general psychiatry.

[40]  D L Alexoff,et al.  Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine , 2006, Synapse.

[41]  S. Kollins,et al.  Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. , 1998, Experimental and clinical psychopharmacology.

[42]  B. Hoza,et al.  A Critical Review of Self-perceptions and the Positive Illusory Bias in Children with ADHD , 2007, Clinical child and family psychology review.

[43]  L. Rohde,et al.  Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study. , 2007, Addiction.

[44]  William Gardner,et al.  Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. , 2003, The American journal of psychiatry.

[45]  D L Newman,et al.  Behavioral observations at age 3 years predict adult psychiatric disorders. Longitudinal evidence from a birth cohort. , 1996, Archives of general psychiatry.

[46]  S. McCabe,et al.  Prevalence and Motives for Illicit Use of Prescription Stimulants in an Undergraduate Student Sample , 2005, Journal of American college health : J of ACH.

[47]  J. Biederman,et al.  Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[48]  D J Rohsenow,et al.  Cue reactivity as a predictor of drinking among male alcoholics. , 1994, Journal of consulting and clinical psychology.

[49]  K. Saules,et al.  Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. , 2002, Experimental and clinical psychopharmacology.

[50]  M. Fillmore,et al.  Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration , 2004, Psychopharmacology.

[51]  F. J. McClernon,et al.  ADHD and Smoking , 2008, Annals of the New York Academy of Sciences.

[52]  N. Volkow,et al.  Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. , 2009, JAMA.

[53]  J. Davidson,et al.  Bupropion sustained release: a therapeutic overview. , 1998, The Journal of clinical psychiatry.

[54]  J. Beuten,et al.  Progress in searching for susceptibility loci and genes for smoking‐related behaviour , 2004, Clinical genetics.

[55]  S. Guthrie,et al.  Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. , 2004, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[56]  S. Kollins,et al.  A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder. , 2005, Journal of child and adolescent psychopharmacology.

[57]  Michael C Neale,et al.  Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. , 2003, The American journal of psychiatry.

[58]  J. Swanson,et al.  A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. , 2006, The Journal of clinical psychiatry.

[59]  Yu-Shin Ding,et al.  Imaging the Effects of Methylphenidate on Brain Dopamine: New Model on Its Therapeutic Actions for Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[60]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[61]  A. Heath,et al.  The role of childhood risk factors in initiation of alcohol use and progression to alcohol dependence. , 2007, Addiction.

[62]  C. Kirstein,et al.  Neurochemical effects of cocaine in adolescence compared to adulthood. , 2005, Brain research. Developmental brain research.

[63]  J. Swanson,et al.  Self-perceptions of competence in children with ADHD and comparison children. , 2004, Journal of consulting and clinical psychology.

[64]  S. Faraone,et al.  Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. , 1995, The American journal of psychiatry.

[65]  J. Smoller,et al.  Molecular Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[66]  N. Volkow,et al.  The addicted human brain: insights from imaging studies. , 2003, The Journal of clinical investigation.

[67]  Frank Telang,et al.  High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. , 2006, Archives of general psychiatry.

[68]  Darin D Dougherty,et al.  PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. , 2006, The American journal of psychiatry.

[69]  T. Eissenberg,et al.  Effects of abstinence and smoking on information processing in adolescent smokers , 2000, Psychopharmacology.

[70]  T. Wilens.  The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. , 2007, The Journal of clinical psychiatry.

[71]  S. Faraone,et al.  A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population , 2009, Molecular Psychiatry.

[72]  M McGue,et al.  Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. , 1999, The American journal of psychiatry.

[73]  R E Tremblay,et al.  Behavior of boys in kindergarten and the onset of substance use during adolescence. , 1997, Archives of general psychiatry.

[74]  Yifeng Xu,et al.  Dopamine D4 receptor polymorphism modulates cue-elicited heroin craving in Chinese , 2006, Psychopharmacology.

[75]  Joseph Biederman,et al.  Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse? , 2003, Pediatrics.

[76]  G. Weiss,et al.  Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. , 1985, Journal of the American Academy of Child Psychiatry.

[77]  R. Baker,et al.  Reinforcing and Subject-Rated Effects of Methylphenidate and d-Amphetamine in Non–Drug-Abusing Humans , 2001, Journal of clinical psychopharmacology.

[78]  Marc A Schuckit,et al.  Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. , 2005, Archives of general psychiatry.

[79]  E. Fombonne,et al.  Hyperactivity-inattention symptoms in childhood and substance use in adolescence: the youth gazel cohort. , 2008, Drug and alcohol dependence.

[80]  D. Fergusson,et al.  Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: results of a 25-year longitudinal study. , 2007, Drug and alcohol dependence.

[81]  Joseph Biederman,et al.  Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study , 2006, Psychological Medicine.

[82]  James Dermody,et al.  Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study. , 2004, Journal of child and adolescent psychopharmacology.

[83]  K. Perry,et al.  Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.

[84]  E. Nunes,et al.  Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. , 2006, Drug and alcohol dependence.

[85]  S. West,et al.  Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies , 2003, Biological Psychiatry.

[86]  M. Monuteaux,et al.  The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us? , 2005, Journal of child and adolescent psychopharmacology.

[87]  J. Swanson,et al.  The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[88]  W. Pelham,et al.  Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. , 2007, Alcoholism, clinical and experimental research.

[89]  Antoine Bechara,et al.  Impaired decision making related to working memory deficits in individuals with substance addictions. , 2004, Neuropsychology.

[90]  C. Kirstein,et al.  Adolescents differ from adults in cocaine conditioned place preference and cocaine-induced dopamine in the nucleus accumbens septi. , 2006, European journal of pharmacology.

[91]  J. Biederman,et al.  Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. , 2005, Journal of child and adolescent psychopharmacology.

[92]  G. August,et al.  Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[93]  E. Miller,et al.  An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.

[94]  M. Fillmore,et al.  Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration , 2005, Psychopharmacology.

[95]  R. Barkley,et al.  The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[96]  R. Barkley,et al.  YOUNG ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: SUBTYPE DIFFERENCES IN COMORBIDITY, EDUCATIONAL, AND CLINICAL HISTORY , 2002, The Journal of nervous and mental disease.

[97]  M. Gill,et al.  No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder. , 2001, American journal of medical genetics.

[98]  J. Nigg,et al.  An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences , 2005, Development and Psychopathology.

[99]  S. McCabe,et al.  Illicit Use of Specific Prescription Stimulants Among College Students: Prevalence, Motives, and Routes of Administration , 2006, Pharmacotherapy.

[100]  R. Barkley,et al.  The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. , 2002, Journal of abnormal psychology.

[101]  S. Faraone,et al.  Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. , 1997, The American journal on addictions.

[102]  S. Faraone,et al.  A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults , 2007, Psychological Medicine.

[103]  F. J. McClernon,et al.  Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study , 2008, Psychopharmacology.

[104]  S. Faraone,et al.  Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. , 2007, The American journal on addictions.

[105]  E. Engleman,et al.  Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: A microdialysis study , 2004, Neuroscience.

[106]  S. Faraone,et al.  ADHD is associated with early initiation of cigarette smoking in children and adolescents. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[107]  S. Tiffany,et al.  A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. , 1990, Psychological review.

[108]  J S Fowler,et al.  Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. , 1995, Archives of general psychiatry.

[109]  J. Nøttestad,et al.  The burden of untreated ADHD among adults: the role of stimulant medication. , 2008, Addictive behaviors.

[110]  K. Bucholz,et al.  Developmental sequence from disruptive behavior diagnosis to adolescent alcohol dependence. , 2001, The American journal of psychiatry.

[111]  Rita Z. Goldstein,et al.  Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction , 2009, Proceedings of the National Academy of Sciences.

[112]  Donna Spruijt-Metz,et al.  Misuse of "study drugs:" prevalence, consequences, and implications for policy , 2006, Substance Abuse Treatment, Prevention, and Policy.

[113]  B. Giros,et al.  Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications , 2006, Biological Psychiatry.

[114]  A. Caspi,et al.  Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. , 2003, Archives of general psychiatry.

[115]  N. Makris,et al.  Structural Brain Imaging of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[116]  E. Foa,et al.  Trauma and women: course, predictors, and treatment. , 1997, The Journal of clinical psychiatry.

[117]  J. Swanson,et al.  Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. , 1996, Molecular psychiatry.

[118]  K. Lynch,et al.  Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. , 2003, Drug and alcohol dependence.

[119]  J. McClellan,et al.  Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[120]  Robert A Zucker,et al.  Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[121]  M. Goldstein.  Bupropion sustained release and smoking cessation. , 1998, The Journal of clinical psychiatry.

[122]  J. McGough,et al.  Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. , 2005, The American journal of psychiatry.

[123]  M. Monuteaux,et al.  Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. , 2008, Archives of pediatrics & adolescent medicine.

[124]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[125]  W. Rinn,et al.  Addiction denial and cognitive dysfunction: a preliminary investigation. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[126]  N. Laurin,et al.  Association study of the nicotinic acetylcholine receptor α4 subunit gene, CHRNA4, in attention‐deficit hyperactivity disorder , 2007, Genes, brain, and behavior.

[127]  Rodney J. Moore,et al.  Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. , 2008, Drug and alcohol dependence.

[128]  M. Munafo,et al.  The genetic basis for smoking behavior: a systematic review and meta-analysis. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[129]  S. Faraone,et al.  Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder , 1999, Pediatrics.

[130]  N. Volkow.  Stimulant medications: how to minimize their reinforcing effects? , 2006, The American journal of psychiatry.

[131]  R. Zucker,et al.  Etiology of alcoholism reconsidered. The case for a biopsychosocial process. , 1986, The American psychologist.

[132]  J. Powell,et al.  Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model , 2002, Biological Psychiatry.

[133]  Mary L Marazita,et al.  Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis , 2002, Psychiatric genetics.

[134]  G. Koob,et al.  The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. , 2006, Addiction.

[135]  S. Kuperman,et al.  Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults , 2001, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[136]  Danielle C. Turner,et al.  Cognitive enhancing effects of modafinil in healthy volunteers , 2002, Psychopharmacology.

[137]  E. Sonuga-Barke,et al.  Psychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition , 2002, Behavioural Brain Research.

[138]  A. Abrantes,et al.  Attention dysfunction predicts substance involvement in community youths. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[139]  P. Riggs,et al.  An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[140]  D. Clark,et al.  Childhood risk categories for adolescent substance involvement: a general liability typology. , 2005, Drug and alcohol dependence.

[141]  D. Hatsukami,et al.  The effects of varying cigarette deprivation duration on cognitive and performance tasks. , 1989, Journal of substance abuse.

[142]  A. Ashley-Koch,et al.  Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[143]  J. Swanson,et al.  Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? , 2008, The American journal of psychiatry.

[144]  P. Riggs,et al.  A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[145]  Nora D. Volkow,et al.  The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies , 2004, Neuropharmacology.

[146]  R. Loeber,et al.  Which aspects of ADHD are associated with tobacco use in early adolescence? , 2001, Journal of child psychology and psychiatry, and allied disciplines.

[147]  M. Monuteaux,et al.  Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[148]  Rita Z. Goldstein,et al.  The Neurocircuitry of Impaired Insight in Drug Addiction , 2009, Trends in Cognitive Sciences.

[149]  J Sergeant,et al.  The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes , 2006, Molecular Psychiatry.

[150]  J. Javitch,et al.  Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. , 2002, Biochemical and biophysical research communications.

[151]  C. Pomerleau,et al.  Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. , 1995, Journal of substance abuse.

[152]  T. Roth,et al.  Sleepiness and the reinforcing and subjective effects of methylphenidate. , 1999, Experimental and clinical psychopharmacology.

[153]  R. Barkley,et al.  Does the treatment of attention‐deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? , 2003, Pediatrics.

[154]  S. Kollins,et al.  Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review , 2001, Pharmacology Biochemistry and Behavior.

[155]  Rodrigo A. Bressan,et al.  Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder - a single Photon Emission Computed Tomography with [Tc99m]TRODAT-1 study , 2008, NeuroImage.

[156]  T. Robbins,et al.  Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[157]  P. Callas,et al.  Potentially modifiable psychosocial factors associated with alcohol use during early adolescence. , 2004, Addictive behaviors.

[158]  J. Swanson,et al.  Efficacy and Safety of Modafinil Film–Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study , 2005, Pediatrics.

[159]  N. Volkow,et al.  Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies , 2002, European Neuropsychopharmacology.

[160]  S. Brown,et al.  Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse. , 1998, The American journal of psychiatry.

[161]  R. Barkley,et al.  Executive Functioning in Hyperactive Children as Young Adults: Attention, Inhibition, Response Perseveration, and the Impact of Comorbidity , 2005, Developmental neuropsychology.

[162]  M. Fillmore,et al.  Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. , 2006, Addiction.

[163]  Frank Telang,et al.  Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. , 2007, Archives of general psychiatry.

[164]  F. Bermúdez-Silva,et al.  The endocannabinoid system: physiology and pharmacology. , 2005, Alcohol and alcoholism.

[165]  M. Dennis,et al.  Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. , 2008, Journal of substance abuse treatment.

[166]  K. Blum,et al.  Handbook of Psychiatric Genetics , 1996 .

[167]  W. Pelham,et al.  Attention-deficit/hyperactivity disordered boys' relationships with their mothers and fathers: Child, mother, and father perceptions , 2003, Development and Psychopathology.

[168]  K. Lynch,et al.  A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence , 2005, Neuropsychopharmacology.

[169]  M. Monuteaux,et al.  Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. , 2008, The American journal of psychiatry.

[170]  S. Hall,et al.  Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[171]  Sarah A. Mustillo,et al.  Prevalence and development of psychiatric disorders in childhood and adolescence. , 2003, Archives of general psychiatry.

[172]  JaneR . Taylor,et al.  Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. , 2003, The American journal of psychiatry.

[173]  L. Rohde,et al.  A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder. , 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[174]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[175]  L. Chait.  Reinforcing and subjective effects of methylphenidate in humans , 1994, Behavioural pharmacology.

[176]  K. Sher.  Children of Alcoholics: A Critical Appraisal of Theory and Research , 1991 .

[177]  M. Martres,et al.  Nicotine Improves Cognitive Deficits of Dopamine Transporter Knockout Mice without Long-Term Tolerance , 2007, Neuropsychopharmacology.

[178]  M S Buchsbaum,et al.  Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. , 1980, Archives of general psychiatry.

[179]  N. Volkow,et al.  The neural basis of addiction: a pathology of motivation and choice. , 2005, The American journal of psychiatry.

[180]  R B Resnick,et al.  Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. , 1977, Science.

[181]  C. Poulin.  Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[182]  S. Kollins,et al.  Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. , 1998, Experimental and clinical psychopharmacology.

[183]  C. Schuster,et al.  Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. , 1973, Journal of the experimental analysis of behavior.

[184]  J. Rapoport,et al.  Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. , 1996, Archives of general psychiatry.

[185]  M. Galanter,et al.  The American Psychiatric Publishing Textbook of Substance Abuse Treatment 4Ed , 2008 .

[186]  W. Barbaresi,et al.  Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. , 2005, Journal of child and adolescent psychopharmacology.

[187]  S. Acheson,et al.  Predictors of Relapse during Treatment and Treatment Completion among Marijuana-Dependent Adolescents in an Intensive Outpatient Substance Abuse Program , 2004, Substance abuse.

[188]  Danielle C. Turner,et al.  Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder , 2004, Biological Psychiatry.

[189]  Julie C. Stout,et al.  Neurocognitive insights into substance abuse , 2005, Trends in Cognitive Sciences.

[190]  W. A. Owens,et al.  CB1‐independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum , 2007, Journal of neurochemistry.

[191]  C. Advokat.  Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD , 2007, Journal of attention disorders.

[192]  Dimitris Samaras,et al.  Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? , 2007, The American journal of psychiatry.

[193]  S. Nelson,et al.  Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. , 2005, Journal of Child Psychology and Psychiatry and Allied Disciplines.

[194]  W. Iacono,et al.  Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. , 2007, Archives of general psychiatry.

[195]  R. Kessler,et al.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. , 2006, The American journal of psychiatry.

[196]  Richard A. Brown,et al.  Psychiatric disorders, familial factors, and cigarette smoking: II. Associations with progression to daily smoking. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[197]  P. Krabbe,et al.  A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. , 2005, Addiction.

[198]  L. Kroutil,et al.  Substance Abuse Treatment, Prevention, and Policy the Nonmedical Use of Prescription Adhd Medications: Results from a National Internet Panel , 2022 .

[199]  C. Pato,et al.  Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. , 1993, American journal of medical genetics.

[200]  Eliza Congdon,et al.  Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: Implications for impulsivity , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[201]  Y. Kaminer,et al.  Megadose Intranasal Methylphenidate (Ritalin) Abuse in Adult Attention Deficit Hyperactivity Disorder , 2002, Substance abuse.

[202]  B. Sahakian,et al.  Professor's little helper , 2007, Nature.

[203]  Hugh Garavan,et al.  Acute effects of cocaine on the neurobiology of cognitive control , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[204]  S. Evans,et al.  Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. , 2007, Drug and alcohol dependence.

[205]  J. Griffith,et al.  Bupropion: clinical assay for amphetamine-like abuse potential. , 1983, The Journal of clinical psychiatry.

[206]  B. Rounsaville,et al.  History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. , 1993, Comprehensive psychiatry.

[207]  M. Monuteaux,et al.  Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. , 2008, The American journal of psychiatry.

[208]  S. Nappo,et al.  Household survey on drug abuse in Brazil: study involving the 107 major cities of the country--2001. , 2005, Addictive behaviors.

[209]  R. Klein,et al.  Hyperactive boys almost grown up. V. Replication of psychiatric status. , 1991, Archives of general psychiatry.

[210]  S. Faraone,et al.  Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? , 1998, Biological Psychiatry.